{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360588381046356224.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.bbadis.2024.167249"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0925443924002382?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0925443924002382?httpAccept=text/plain"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380588381046356229","@type":"Researcher","foaf:name":[{"@value":"Aya Shiba-Ishii"}]},{"@id":"https://cir.nii.ac.jp/crid/1380588381046356240","@type":"Researcher","foaf:name":[{"@value":"Takayuki Isagawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1380588381046356121","@type":"Researcher","foaf:name":[{"@value":"Toshihiro Shiozawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1380588381046356116","@type":"Researcher","foaf:name":[{"@value":"Naoko Mato"}]},{"@id":"https://cir.nii.ac.jp/crid/1380588381046356232","@type":"Researcher","foaf:name":[{"@value":"Tomoki Nakagawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1380588381046356114","@type":"Researcher","foaf:name":[{"@value":"Yurika Takada"}]},{"@id":"https://cir.nii.ac.jp/crid/1380588381046356115","@type":"Researcher","foaf:name":[{"@value":"Kanon Hirai"}]},{"@id":"https://cir.nii.ac.jp/crid/1380588381046356100","@type":"Researcher","foaf:name":[{"@value":"Jeongmin Hong"}]},{"@id":"https://cir.nii.ac.jp/crid/1380588381046356097","@type":"Researcher","foaf:name":[{"@value":"Anri Saitoh"}]},{"@id":"https://cir.nii.ac.jp/crid/1380588381046356112","@type":"Researcher","foaf:name":[{"@value":"Norihiko Takeda"}]},{"@id":"https://cir.nii.ac.jp/crid/1380588381046356102","@type":"Researcher","foaf:name":[{"@value":"Toshiro Niki"}]},{"@id":"https://cir.nii.ac.jp/crid/1380588381046356234","@type":"Researcher","foaf:name":[{"@value":"Yoshinori Murakami"}]},{"@id":"https://cir.nii.ac.jp/crid/1420282801201722368","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"80415554"},{"@type":"NRID","@value":"1000080415554"},{"@type":"NRID","@value":"9000107354075"},{"@type":"NRID","@value":"9000001707178"},{"@type":"NRID","@value":"9000024993505"},{"@type":"NRID","@value":"9000402233443"},{"@type":"NRID","@value":"9000004888637"},{"@type":"NRID","@value":"9000412189968"},{"@type":"NRID","@value":"9000402931100"},{"@type":"NRID","@value":"9000020737317"},{"@type":"NRID","@value":"9000004126257"},{"@type":"NRID","@value":"9000317165235"},{"@type":"NRID","@value":"9000403151059"},{"@type":"NRID","@value":"9000001949482"},{"@type":"NRID","@value":"9000011118030"},{"@type":"NRID","@value":"9000002249561"},{"@type":"NRID","@value":"9000401737038"},{"@type":"NRID","@value":"9000258181963"},{"@type":"NRID","@value":"9000010221747"},{"@type":"NRID","@value":"9000401419589"},{"@type":"NRID","@value":"9000006847393"},{"@type":"NRID","@value":"9000006344280"},{"@type":"NRID","@value":"9000021557721"},{"@type":"NRID","@value":"9000345196659"},{"@type":"NRID","@value":"9000018723213"},{"@type":"NRID","@value":"9000018833098"},{"@type":"NRID","@value":"9000018776972"},{"@type":"NRID","@value":"9000399380701"},{"@type":"NRID","@value":"9000406206040"},{"@type":"NRID","@value":"9000258044784"},{"@type":"NRID","@value":"9000004378712"},{"@type":"NRID","@value":"9000242711092"},{"@type":"NRID","@value":"9000388457839"},{"@type":"NRID","@value":"9000242084663"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/pathol"}],"foaf:name":[{"@value":"Daisuke Matsubara"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09254439"}],"prism:publicationName":[{"@value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2024-08","prism:volume":"1870","prism:number":"6","prism:startingPage":"167249"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","http://www.elsevier.com/open-access/userlicense/1.0/","https://doi.org/10.15223/policy-017","https://doi.org/10.15223/policy-037","https://doi.org/10.15223/policy-012","https://doi.org/10.15223/policy-029","https://doi.org/10.15223/policy-004"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0925443924002382?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0925443924002382?httpAccept=text/plain"}],"createdAt":"2024-05-18","modifiedAt":"2025-08-01","project":[{"@id":"https://cir.nii.ac.jp/crid/1040291932584112512","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"22K06945"},{"@type":"JGN","@value":"JP22K06945"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K06945/"}],"notation":[{"@language":"ja","@value":"低接着スフェロイド培養を用いた肺腺癌の転移機構の解析"},{"@language":"en","@value":"Analysis of the mechanisms of metastasis of lung adenocarcinoma by low-attachment spheroid culture"}]},{"@id":"https://cir.nii.ac.jp/crid/1040299826879537920","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23K24102"},{"@type":"JGN","@value":"JP23K24102"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K24102/"}],"notation":[{"@language":"ja","@value":"HNF4α陽性肺腺癌の組織学的特徴を踏まえた、発癌、転移、代謝のメカニズムの解明"},{"@language":"en","@value":"Elucidation of carcinogenesis, metastasis and metabolic mechanisms in HNF4A-positive lung tumor"}]},{"@id":"https://cir.nii.ac.jp/crid/1040581301859494016","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"24K02319"},{"@type":"JGN","@value":"JP24K02319"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24K02319/"}],"notation":[{"@language":"ja","@value":"細胞接着分子群の特性と体質の解明に基づくがんの新規診断、治療法の確立と意義の解明"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050304183896093184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1050564285808202368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A secondary RET mutation in the activation loop conferring resistance to vandetanib"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002216808216704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"RET, ROS1 and ALK fusions in lung cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002218683460992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Synthetic Lethality–Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168884350720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Gene expression profiles of the original tumors influence the generation of PDX models of lung squamous cell carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013170088094592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013171278812672","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017290191694976","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinicopathologic Characteristics of BRG1-Deficient NSCLC"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396523990656","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025437251923328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Polymorphic variants at NDUFC2, encoding a mitochondrial complex I subunit, associate with cardiac hypertrophy in human hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283691784925696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"KIF5B-RET fusions in lung adenocarcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283691784931712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283692736095744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Identification of CCDC6-RET Fusion in the Human Lung Adenocarcinoma Cell Line, LC-2/ad"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643795569408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294645934891904","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294647536194816","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Genomic Landscape of\n                    <i>SMARCA4</i>\n                    Alterations and Associations with Outcomes in Patients with Lung Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579817459401728","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Final survival results for the LURET phase II study of vandetanib in previously treated patients with RET-rearranged advanced non-small cell lung cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580235937386496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588383973798784","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mitochondrial dysfunction and chromatin changes with autophagy-mediated survival in doxorubicin resistant cancer cell lines"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658398357376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659825949568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855567866372736","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comprehensive molecular profiling of lung adenocarcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569923321216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570396300672","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Lack of Oxidative Phosphorylation and Low Mitochondrial Membrane Potential Decrease Susceptibility to Apoptosis and Do Not Modulate the Protective Effect of Bcl-xL in Osteosarcoma Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861710914241152","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869863780767616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Chemical and physical fixation of isolated mitochondria in low-energy and high-energy states."}]},{"@id":"https://cir.nii.ac.jp/crid/1360869863948049408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Small-Cell Lung Cancer Transformation as a Mechanism of Resistance to Pralsetinib in RET-Rearranged Lung Adenocarcinoma: A Case Report"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869864177147776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Therapy-induced APOBEC3A drives evolution of persistent cancer cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137043758558592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520483923328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418521216710912","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mitochondria and reactive oxygen species"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468462987904","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Efficacy of Selpercatinib in\n            <i>RET</i>\n            Fusion–Positive Non–Small-Cell Lung Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469546339712","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469635345152","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470892415232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369889822592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Selective RET kinase inhibition for patients with RET-altered cancers"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370576972160","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844128805248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"ULTRASTRUCTURAL BASES FOR METABOLICALLY LINKED MECHANICAL ACTIVITY IN MITOCHONDRIA"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318626671360","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mitochondrial mutations in cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794531053952","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951796079745536","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Global Patterns of Cancer Incidence and Mortality Rates and Trends"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269120357504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1370588381046356107","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation"}]},{"@id":"https://cir.nii.ac.jp/crid/1370588381046356119","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cancer statistics, 2023"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572701522922752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.bbadis.2024.167249"},{"@type":"KAKEN","@value":"PRODUCT-25469270"},{"@type":"KAKEN","@value":"PRODUCT-25660722"},{"@type":"KAKEN","@value":"PRODUCT-25687698"}]}